location:
Home    New in Launch    SEMAGLUTIDE

SEMAGLUTIDE

Product introduction

 

  Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide has the potential for type 2 diabetes treatment;

Biosimilar by fermentation